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To prevent injury to host tissues, complement activation is
regulated by a number of plasma and membrane-associated
proteins, most of which limit C3 and C5 activation. An influx
of circulating C3 from a syngeneic host into donor kidneys
deficient in Crry (a membrane protein that reduces C3
convertase activity) causes spontaneous complement
activation, primarily in the tubulointerstitum, leading
to renal failure. To determine the roles of the C3a and C5a
anaphylatoxins in tubulointerstitial inflammation and
fibrosis, kidneys from Crry/C3/ mice were transplanted
into hosts lacking the C3a and/or C5a receptor. While
unrestricted complement activation in the tubules was not
affected by receptor status in the transplant recipient, C3a
receptor deficiency in the recipients led to significantly
reduced renal leukocyte infiltration and the extent of
tubulointerstitial inflammation and fibrosis, all of which led
to preserved renal function. The absence of C5a receptors in
recipients was not only inconsequential, but the protective
effect of C3a receptor deficiency was also eliminated,
suggesting distinct roles of C3a and C5a receptor signaling in
this model. There was significant infiltration of the
tubulointerstitum with 7/4þF4/80þCD11bþ
myelomonocytic cells and Thy1.2þ T cells along injured
tubules, and interstitial collagen I and III deposition, all of
which were C3a receptor dependent. Thus, blockade of C3a
receptor signaling is a possible treatment to reduce renal
inflammation and preserve renal function associated with
complement activation.
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To prevent injury to host tissues, complement activation is
strictly regulated by a number of plasma and cell membrane-
associated proteins, most of which are concentrated on
limiting C3 and C5 activation, consistent with the potency of
their activated products.1 In humans, decay-accelerating
factor (CD55) and membrane cofactor protein (CD46) are
the main membrane-bound intrinsic regulators of C3
activation. In rodents, CR1-related gene/protein y (Crry) is
a 65-kDa complement regulatory protein that combines both
of their decay-accelerating and factor I–cofactor activities into
one protein.2
Crry gene-targeted mice have embryonic lethality because
of unrestricted complement activation and concomitant
placental inflammation that can be rescued by coexisting
C3 deficiency in Crry/C3/ mice.3 We have shown that Crry
is critical to protecting the normal kidney from complement
attack by transplanting kidneys from Crry/C3/ mice
into syngeneic complement-sufficient wild-type (WT)
C57BL/6 mice. The influx of circulating C3 from the host
into the Crry-deficient kidney led to spontaneous comple-
ment activation primarily in the tubulointerstitum (TI),
with inflammation and subsequent renal failure.4 Consistent
with our findings, recent studies from the Thurman
laboratory have shown that Crry prevents alternative pathway
activation on the basolateral surface of murine proximal
tubular cells.5 Although this complement activation-induced
renal TI injury model is arbitrary in many aspects, it shares
many features of primary or secondary TI damage occurring
in human glomerular and tubulointerstitial diseases, includ-
ing TI inflammation, tubular cell injury, and development
of renal fibrosis. It is well known in a variety of renal diseases
that TI damage, including the extent of TI inflammation, is
the best predictor of renal functional outcome (for example,
even more than the severity of glomerular injury in primary
glomerular diseases).6,7
The anaphylatoxins C3a and C5a are generated when C3
and C5 are cleaved by their respective C3 and C5 convertases.8
C3a and C5a exert their functions by binding to their
G-protein-coupled receptors (R), C3aR and C5aR, present on
most myeloid cells, including neutrophils, macrophages, and
activated T cells.9–13 C3a and C5a contribute to the
inflammatory responses such as leukocyte accumulation and
enhancement of vascular permeability occurring in various
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inflammatory diseases.8 C3a and C5a are chemotactic for
eosinophils,14,15 mast cells,16 neutrophils, macrophages,17 and
activated T cells.12 C3a and C5a possess many other functions
beyond their promoting inflammation, such as regulation of
liver regeneration18 and T-cell immune responses.19,20
To examine the effects of C3aR and C5aR signaling in
the renal inflammation occurring in Crry-deficient kidneys,
we transplanted kidneys from Crry/C3/ mice into C3aR
and/or C5aR gene-targeted mice. In these experimental
conditions, all transplanted kidneys were Crry deficient in
which there was substantial complement activation and
generation of C3a and C5a, whereas the otherwise syngeneic
host lacked C3aR and/or C5aR. Our observation from this
unique model suggests that C3aR signaling is essential in
renal inflammation due to complement activation, whereas
the beneficial effects of C3aR deficiency were reversed when
C5aR was also absent.
RESULTS
Absent host C3aR signaling attenuates complement-
induced renal failure
Crry/C3/ kidneys transplanted into syngeneic WT mice
have spontaneous complement activation within the TI,
leading to inflammation, fibrosis, and renal failure within
weeks.4 Here we evaluated the roles for C3aR and C5aR
signals in inflammatory cells recruited into the Crry-deficient
kidney by transplanting Crry/C3/ kidneys into C3aR/,
C5aR/, C3aR/C5aR/, and WT hosts.
The relevance of host cellular C3aR and/or C5aR signaling
on the functional renal failure that occurs in Crry-deficient
kidneys was first determined. To do this, bilateral native
nephrectomies were performed, the first at the time of
transplantation and the second 7 days later. Thus, renal
function from 7 to 21 days post transplantation was solely
dependent on the transplanted Crry-deficient kidney. As
shown in Figure 1, blood urea nitrogen values in C3aR/
recipients were significantly lower than those in C5aR/,
C3aR/C5aR/, and WT recipients (P¼ 0.047; Table 1
shows a summary of these and subsequent data). Thus,
deficiency of C3aR in the hosts significantly protected
transplanted Crry-deficient kidneys from renal failure.
Surprisingly, this protection appeared to be lost in the
combined absence of C5aR signaling. This was evaluated
further in subsequent studies.
Crry-deficient kidneys in C3aR-deficient but not C5aR-
deficient recipient mice are protected from TI injury
Given that unrestricted complement activation underlies the
severe renal damage in Crry-deficient kidneys, the extent of
complement deposition in transplanted kidneys was evalu-
ated. Upon restoration of blood flow after kidney transplan-
tation, the influx of circulating C3 initiates complement
activation in transplanted Crry-deficient kidneys, as revealed
by considerable C3 deposition along the basolateral aspects of
tubular cells by immunofluorescence microscopy; comple-
ment was also activated within the endothelium of the TI
(that is, vasa recta) but not within glomeruli.4 At 7 days after
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Figure 1 |Renal failure occurred in C5aR/, C3aR/C5aR/,
and wild-type (WT), but not C3aR/, recipients of Crry-
deficient kidneys. Kidneys from Crry/C3/ mice were
transplanted into C3aR/, C5aR/, C3aR/C5aR/, and WT
mice in which both native kidneys were removed after 7 days.
Shown are blood urea nitrogen (BUN) levels in individual
recipients from each group 21 days after transplantation.
*P¼ 0.047 versus C5aR/, C3aR/C5aR/, and WT groups.
Table 1 | Phenotype of Crry/C3/ kidneys transplanted into C3aR/, C5aR/, C3aR/C5aR/, and WT recipients
C3aR/ C5aR/ C3aR/C5aR/ WT
Day 7
TIN (0–4) 0.5 (0–1.5) 1.5 (0.5–2.0) 1.5 (1.0–3.0) 1.5 (0.5–2.0)
7/4+ cellsa (no./ 200 field) 63.3±6.7 156.5±21.6 146.4±23.0 140.2±16.2
F4/80+ cellsa (no./ 200 field) 64.5±10.1 129.9±11.8 146.1±21.2 130±21.1
Thy1.2+ cells (no./ 200 field) 12.8±4.0 77.7±10.6 113.2±16.1 69.3±11.7
PCNA+ cells (no./ 200 field) 8.0±2.0 15.3±2.3 16.1±1.7 16.0±1.4
Day 21
BUNb (mg/dl) 35.5 (32.8–40.7) 46.6 (38.2–105.2) 49.4 (35.6–124.3) 62.5 (42.5–98.6)
Collagen I (0–4) 2.0 (1.5–2.5) 2.8 (2.0–3.0) 2.5 (2.5–3.0) 3.0 (2.5–3.0)
Collagen III (0–4) 2.5 (2.0–3.0) 3.8 (2.0–4.0) 3.5 (3.0–4.0) 3.5 (3.0–4.0)
Abbreviations: BUN, blood urea nitrogen; PCNA, proliferating cell nuclear antigen; TIN, tubulointerstitial nephritis; WT, wild type.
aCharacterized as F4/80+Ly-6+CD11b+ (see text for details).
bFollowing bilateral native nephrectomies.
Data are means±s.e.m.’s for parametric data, and medians with ranges in parentheses for nonparametric data.
For each variable, data from C3aR/ recipients were significantly less (Po0.05) than those from C5aR/, C3aR/C5aR/, and WT recipients.
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transplantation, the intensity of the renal tubular C3
deposition in Crry-deficient kidneys was no different among
the four recipient groups, with staining scores (as medians
with ranges in parentheses) of 1.5 (1.0–2.5), 2.0 (1.0–2.5), 2.0
(1.0–2.5), and 2.0 (1.0–2.5) in C3aR/, C5aR/,
C3aR/C5aR/, and WT mice, respectively (Figure 2a).
Thus, not unexpectedly, the absence of C3aR and/or C5aR in
the transplant recipients did not affect the extent or
distribution of spontaneous complement activation occur-
ring in Crry-deficient kidneys. This allowed us to investigate
the roles for C3aR and/or C5aR signaling in host-derived cells
in complement activation-initiated TI injury.
Within 7 days after transplantation of Crry/C3/
kidneys into C3-sufficient WT hosts, there was inflammatory
cell infiltration, tubular dilation, and atrophy, and the
beginnings of interstitial fibrosis.4 As with WT recipients,
C5aR/ recipients developed significant TI nephritis. In
contrast, C3aR/ recipients had significantly less inflamma-
tory cell infiltration, tubular dilation, and atrophy (Figure
2a). Interestingly, the protective effect of C3aR deficiency
was mitigated when C5aR was also absent in recipient
C3aR/C5aR/ mice. The severity of TI nephritis in each
kidney was semiquantified in a scale from 0 to 4 in 0.5
increments as described previously.4 Crry-deficient kidneys
in the C3aR/ hosts had significantly lower TI nephritis
scores than those in the C5aR/, C3aR/C5aR/, or WT
hosts (Figure 2b), whereas there was no significant difference
between the latter three groups.
C3aR and C5aR dependence of inflammatory cell
recruitment into the TI of Crry-deficient kidneys
By histopathological criteria, there was considerable inflam-
matory cell infiltration into Crry-deficient kidneys
transplanted into C5aR/, C3aR/C5aR/, and WT
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Figure 2 | Light and immunofluorescence (IF) microscopic features of Crry-deficient kidneys transplanted into C3aR/, C5aR/,
C3aR/C5aR/, and wild-type (WT) recipients. (a) Shown is representative IF staining for C3 and periodic acid-Schiff (PAS) staining
in Crry-deficient kidneys transplanted into C3aR/, C5aR/, C3aR/C5aR/, or WT recipients 7 days after transplantation. Crry-deficient
kidneys in all groups had marked C3 staining around the basolateral aspects of tubules. Crry-deficient kidneys in C5aR/, C3aR/C5aR/,
and WT recipients had marked inflammation and tubular injury, characterized by tubular dilatation and cellular sloughing, which were
largely absent in C3aR/ recipients. Original magnifications  200. (b) Tubulointerstitum (TI) nephritis scores in individual animals from
each group of transplant recipients are shown. *P¼ 0.036 vs C5aR/, C3aR/C5aR/, and WT groups.
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recipients,4 whereas C3aR/ recipients had significantly less
inflammation. It is likely the latter translated into protection
from TI injury and ultimate renal failure.
To provide further insights into how signaling through
C3aR and C5aR affected this TI inflammation, we evaluated
the composition of infiltrating cells. Crry-deficient kidneys in
C5aR/, C3aR/C5aR/, and WT recipients had con-
siderable infiltration with 7/4þ (Ly-6B.2þ ) myeloid cells and
Thy1.2þ T cells, which was substantially less in the C3aR/
recipients (Figure 3a and b). There was also a significant
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Figure 3 |Cellular characterization of tubulointerstitial infiltrates in transplanted Crry-deficient kidneys. (a) Shown is representative
immunohistochemical staining for 7/4þ and Thy1.2þ cells in Crry/C3/ kidneys 7 days after transplantation into C3aR/, C5aR/,
C3aR/C5aR/, and wild-type (WT) recipients. (b) Quantification of 7/4þ , Thy1.2þ , F4/80þ , and B220þ cells in the four groups. Data are
the average of cell counts per  200 field in individual kidneys. *Po0.01, #Po0.05 versus C5aR/, C3aR/C5aR/, and WT recipients.
(c) Representative double staining for 7/4þ , Thy1.2þ , and F4/80þ cells demonstrates their marked infiltration around injured (dilated)
tubules and perivascular areas of Crry-deficient kidneys transplanted into C3aR/C5aR/ hosts. Original magnifications  200.
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increase in the numbers of F4/80þ (EGF-like module
containing, mucin-like, hormone receptor-like sequence 1
(EMR1)þ ) myelomonocytic cells in Crry-deficient kidneys in
C5aR/, C3aR/C5aR/, and WT recipients when
compared with C3aR/ recipients (Figure 3b). There
was only a minor infiltration with B220þ B cells in all
kidneys; although there were greater numbers in C5aR/,
C3aR/C5aR/, and WT recipients compared with
C3aR/ recipients, these were not statistically significant
(Figure 3b). By dual immunohistochemical staining, there
was a clear mixture of 7/4þ , F4/80þ , and Thy1.2þ cells
mostly accumulating along dilated (injured) tubules in trans-
planted Crry-deficient kidneys in C5aR/, C3aR/C5aR/,
and WT recipients (examples from the latter are shown in
Figure 3c). By this immunohistochemical approach, we were
unable to separate 7/4þ and F4/80þ cells, suggesting that these
two markers were largely present on the same cell type(s).
Given the marked inflammation of Crry-deficient kidneys
in C3aR/C5aR/ recipients with 7/4þ and F4/80þ cells,
we further characterized these cells by flow cytometry of
isolated renal cells. For this approach, we used monoclonal
antibodies (mAbs) Gr1 (to Ly-6C/Ly-6G, closely related to
Ly-6B.2 (see Rosas et al.21), F4/80 (to EMR1), and those
reactive with CD11b and CD11c, given the differential
expression of these four antigens on neutrophils, mono-
cytes/macrophages, and renal dendritic cells.22,23
As shown in Figure 4a (middle and bottom panels),
kidneys from Crry/C3/ donors transplanted into
C5aR/ (data not shown), C3aR/C5aR/, and WT hosts
had a substantial F4/80þ cellular population, relative to the
Crry/C3/ kidneys transplanted into C3aR/ hosts (top
panel). The normal population of F4/80þCD11cþ dendritic
cells did not appear to be affected (left panel), whereas there
was an expanded population of F4/80þCD11bþ cells. There
was a significant population of Gr1þ cells present in
transplanted Crry-deficient kidneys in C5aR/ (data not
shown), C3aR/C5aR/, and WT hosts, which were absent
in the Crry/C3/ kidneys transplanted into C3aR/ hosts
(Figure 4a, right panel). These cells could be further identified
as F4/80þCD11bþ (Figure 4b). Thus, the renal TI in Crry-
deficient kidneys in a C5aR/, C3aR/C5aR/, or WT
recipient was infiltrated with cells that could be characterized
primarily as F4/80þGr1þCD11bþ cells. Of note, there were
comparable amounts and cell marker expression patterns of
105
105
104
C3
aR
–
/–
C3
aR
–
/–
C3
aR
–
/–
 
C5
aR
–
/–
C3
aR
–
/–
 
C5
aR
–
/–
W
T
W
T
Host: Host:
CD
11
b
CD11c
SS
C
SS
C
F4/80 Gr1 Gr1 CD11b
F4
/8
0
CD
11
b
0.926
81.7
2.14
0.839
0.876
25.5
86
62.5
4.1
5.49
35.7
5.53
29.8
4.25
41.7
28.3
34.1
47.9
104
103
103
102
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
105
104
103
102
0
0
1051041031020
1051041031020
1051041031020
1051041031020 1051041031020
1051041031020
1051041031020 1051041031020 1051041031020
1051041031020 1051041031020
1051041031020 1051041031020
1051041031020
Figure 4 |Coexpression of F4/80, Gr1, and CD11b on cells infiltrating the tubulointerstitum (TI) of Crry-deficient kidneys
transplanted into complement-sufficient hosts. (a) Flow cytometric analyses of cells isolated from Crry-deficient kidneys transplanted
into C3aR/, C3aR/C5aR/, and wild-type (WT) hosts show that the F4/80þ cells were Gr1þCD11bþ . (b) Gr1þ cells were also F4/
80þCD11bþ . These F4/80þGr1þCD11bþ cells were not present in Crry-deficient kidneys transplanted into C3aR/ hosts (shown in the
top panels).
Figure 5 | Expression of proliferating cell nuclear antigen (PCNA) in tubular cells and collagens I and III in the tubulointerstitum (TI)
of Crry-deficient kidneys in complement-sufficient hosts. (a) Representative immunohistochemical staining for PCNA, illustrating the
wide distribution of PCNAþ tubular cells in Crry-deficient kidneys in C5aR/, C3aR/C5aR/, and wild-type (WT) hosts, and their reduced
numbers in C3aR/ hosts. (b) Quantification of PCNAþ tubular cells. Data are the average of cell counts per  200 field in individual
kidneys. *Po0.05 versus C5aR/, C3aR/C5aR/, and WT groups. (c) Dual immunofluorescence (IF) staining showing the accumulation of
collagens I and III (red) along the CD11bþ (green) infiltrating cells, which was reduced in Crry-deficient kidneys in C3aR/ recipients.
(d) Quantification of collagen I and III deposition. Shown is the intensity of staining (0–4) in individual Crry-deficient kidneys in the three
groups. #P¼ 0.030; **P¼ 0.040 versus C5aR/, C3aR/C5aR/, and WT groups.
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F4/80þGr1þCD11bþ cells and Thy1.2þ T cells in the Crry-
deficient kidneys transplanted in C5aR/, C3aR/C5aR/,
and WT hosts. Consistent with the findings using immuno-
histochemistry staining, flow cytometry showed considerably
lesser numbers of F4/80þGr1þCD11bþ cells in C3aR/
recipients, at levels comparable with normal kidneys. Thus,
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unrestricted complement activation in Crry-deficient kidneys
resulted in C3aR signaling-dependent recruitment of F4/
80þCD11bþCD11cþ / macrophages with proinflammatory
Gr1 antigen/Ly-6 expression.24,25
Absence of C3aR signaling attenuated TI cellular injury
and collagen accumulation
As a marker for preceding cellular injury, the presence
of proliferating cell nuclear antigen was determined.
Proliferating cell nuclear antigen-positive tubular cells were
widely observed in the Crry-deficient kidneys in C5aR/,
C3aR/C5aR/, and WT hosts, especially in the tubules
with histopathological evidence for injury, such as tubular
dilation and cellular sloughing. In contrast, Crry-deficient
kidneys in C3aR/ hosts with intact C5aR had significantly
fewer proliferating cell nuclear antigen-positive tubular cells
(Figure 5a and b). Thus, although there was equivalent
complement activation in the Crry-deficient kidneys, tubular
cell injury was significantly reduced in the setting of host
C3aR deficiency, presumably reflecting a role for inflamma-
tory cells in this injury response.
To address the contribution of infiltrating cells to the
accumulation of collagens and fibrosis in the TI, and
eventually the development of renal failure, double immuno-
fluorescence staining for CD11b and collagens I and III
was performed. At 21 days after renal transplanta-
tion, extensive collagen I and III deposition was found
around the interstitial infiltrating cells in the C5aR/,
C3aR/C5aR/, and WT groups, but not in the C3aR/
group (Figure 5c). Semiquantitative scoring for collagen I
and III accumulation confirmed that significantly less
collagen I and III was present in the Crry-deficient kidneys
in C3aR/ recipients (Figure 5d).
DISCUSSION
In this study, we investigated TI injury occurring in Crry/
C3/ mouse kidneys transplanted into C3-sufficient WT
hosts, in which setting there is local unrestricted complement
activation.4 The roles for signaling through extrarenal
anaphylatoxin receptors C3aR and C5aR were investigated
by transplanting kidneys from Crry/C3/ mice into
C3aR/ and/or C5aR/, as well as WT control hosts. In
all instances, there was substantial tubular C3 deposition
in Crry-deficient kidneys, and thus the absence of C3aR
and/or C5aR did not appear to alter the marked complement
activation that occurs in this model. Relative to WT and
C5aR/ recipients with intact C3aR, Crry-deficient kidneys
in C3aR/ recipients had substantially reduced acute TI
inflammation, and subsequent development of tubular injury,
fibrosis, and functional renal failure (Table 1). Thus, C3aR
signaling in extrarenal cells appears critical for the cascade of
events that rapidly culminates in end-stage kidney disease in
this model.
That C3aR signaling is relevant in TI inflammation and
fibrosis is supported by studies in the adriamycin-induced
proteinuric model of TI damage, in which C3aR/ mice
were significantly protected from tubular injury and fibrosis,
and did not develop renal failure as WT mice did.26 Although
these observations in C3aR/ mice necessarily had absent
C3aR signaling on all cells (that is, renal and extrarenal),
the potential that tubular cell C3aR signaling is directly
relevant has been postulated. Studies with cultured tubular
epithelial cells have shown that C3aR inhibition led to
reduced expression of CXC chemokines (upregulated in renal
ischemia/reperfusion)27 and prevented C3a and serum-induced
epithelial-to-mesenchymal transition.26 In our studies, all
transplanted kidneys had the same Crry/C3/ genotype,
whereas C3aR was absent exclusively in the recipient,
allowing us to conclude that C3aR signaling in extrarenal
inflammatory cells was pathogenic in this model. We were
unable to assign a role for intrinsic renal cellular C3aR
signaling in this model; to do this, transplantation of
Crry/C3/C3aR/ kidneys into WT mice will be
required, which is the topic of future studies.
That C5aR signals can be relevant in TI injury/fibrosis is
supported by studies in the unilateral ureteral obstruction
model, in which a C5aR antagonist ameliorated renal fibrosis
and also inhibited C5a-stimulated production of transform-
ing growth factor-b1 in cultured murine cortical tubular
cells.28 In our studies, Crry/C3/ kidneys in C5aR/
recipients developed TI inflammation, fibrosis, and renal
failure comparable with WT recipients,4 illustrating that
C5aR activation in inflammatory cells does not contribute to
the pathogenesis of this model. However, a role for C5aR
signals in extrarenal cells is not irrelevant in this model,
because the protection from TI disease in C3aR/ hosts was
lost when C5aR was also absent in C3aR/C5aR/
recipients. Thus, signals through extrarenal C5aR may have
a dampening role on the renal inflammation induced by
excessive complement activation and signaling through
C3aR.
C3aR and C5aR have similar structure, and functions that
overlap in some instances, are separate in others, and
completely disparate in others, prompting their being coined
‘salt and pepper’ by Steven Sacks.29 Opposing effects of
signals through C3aR and C5aR could be attributable to
differential expression on different cell types, the use of
separate signals through the same cell, or counter-regulation
of their expression.30 The unique and, at times, contrasting
functions of C3aR and C5aR have been illustrated by
experimental models of sepsis,31,32 systemic lupus erythema-
tosus,33,34 and allergic asthma19,30,35–38 in C3aR/ and
C5aR/ mice. For example, in experimental allergic asthma
mediated by a Th2 immune response, C3aR activation
promoted Th2 responses and airway inflammation, thus
preventing C3aR signaling-ameliorated disease.19,35 Of con-
siderable relevance to our current study, the relative
resistance of C3aR/ mice to allergic asthma was reversed
when C5aR was blocked, illustrating the presence of
protective signals through C5aR in this model.38
Deficiency of host C3aR led to significantly reduced renal
TI inflammation in the transplanted Crry-deficient kidney,
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characterized by infiltrates of Thy1.2þ T cells and cells
stained with mAbs 7/4 and F4/80 to myeloid antigens, Ly-
6B.2 and EMR1, respectively. In follow-up flow cytometry
studies, we could conclude that the majority of these latter
cells were F4/80þGr1þCD11bþ cells. Given the expression
of F4/80 antigen/EMR1 and CD11b, these cells are mono-
cyte–macrophage in nature. Although the Ly-6 antigens
identified by mAbs 7/4 and Gr1 are highly expressed on
neutrophils, they are not restricted to these cells, as they are
also present on recently generated macrophages with
inflammatory properties.21,24,25 Therefore, signals through
C3aR appear critical in recruiting inflammatory macrophages
and T cells.
The reduction of infiltrating cells by host C3aR deficiency
was in turn followed by significantly less proliferating cell
nuclear antigen-positive cells, collagen I and III accumula-
tion, and renal failure. Cells of monocytic lineage play critical
roles in renal inflammation and fibrosis; for example, Gr1þ
CD11bþCD115þ cells can differentiate into collagen type I-
producing fibrocytes in vitro and in vivo, such as in unilateral
ureteral obstruction model.39 In this model, severe combined
immunodeficiency mice or mice with preceding CD4þ cell
depletion had significantly less fibrocytes and collagen I
deposition compared with control WT mice, whereas the
total numbers of renal-infiltrating CD45þ cells were
comparable in all mice, suggesting that CD4þ T cells were
essential for the differentiation of Gr1þ CD11bþCD115þ
monocytes into collagen type I-producing fibrocytes.39 In the
present study, type I and III collagen accumulated mainly at
the sites of infiltrating cells, and thus it is feasible that
colocalized Thy1.2þ T cells promoted differentiation of
F4/80þGr1þCD11bþ cells into fibrocytes in the intersti-
tium, promoting renal fibrosis and ultimate development of
renal failure.
In renal inflammation, locally produced chemokines
can play critical roles in the localization and function of
cells infiltrating the kidney.40,41 Gene profiling experiments
from our previous study revealed a large number of
proinflammatory and profibrotic chemokine genes that
were upregulated in the Crry-deficient kidneys transplanted
into WT hosts.4 These chemokines were induced upon
complement activation, and likely contributed to inflamma-
tory cell infiltration, fibrosis, and renal failure. One
important chemokine is monocyte chemoattractant pro-
tein-1, which plays a key role in macrophage activation and is
implicated in renal fibrosis occurring in different renal
diseases. For example, blockade of monocyte chemoattrac-
tant protein-1 receptor CCR2 (chemokine (C-C motif)
receptor 2) in the unilateral ureteral obstruction model
significantly reduced F4/80þ macrophage interstitial infiltra-
tion and subsequently ameliorated renal fibrosis and type I
collagen expression.42
Besides production of soluble C3a capable of acting
through C3aR on inflammatory cells, C3 activation leads to
generation of C3b, which is promiscuous in its covalent
association with available carbohydrate or amino-acid
residues. Cleavage of C3b by factor I plus a cofactor such
as factor H (from plasma or locally generated by endothe-
lium43) leads to generation of iC3b, which is a ligand for
inflammatory cell b2 integrin CD11b/CD18 (also termed
complement receptor 3 to reflect such binding).44 In this
study, Crry-deficient kidneys transplanted into complement-
sufficient hosts had substantial C3 deposition around which
were CD11bþ myelomonocytic cells, suggesting the rele-
vance of CD11b/CD18 interactions with iC3b. CD11b/CD18
binding can lead to adhesion of leukocytes, such as to iC3b-
coated endothelial cells.43 Yet, CD11b/CD18 is intrinsically
inactive, and is only activated by iC3b when there is an
additional signal, such as generated experimentally by
phorbol myristate acid.45 More recently, it has become clear
that activation of G-protein-coupled receptors, such as C3aR
and C5aR, as well as immunoreceptor tyrosine-based
activation motif-containing proteins, such as FcgRs, can
have significant effects on CD11b/CD18 functions, although
these involve pathways that are still incompletely under-
stood.46 In this model system, it is unlikely that FcgRs were
relevant. Our data would suggest that, at least in this model
of TI complement activation and inflammatory cell accu-
mulation, C3aR signals promote the binding/activation of
CD11b/CD18 on inflammatory cells, whereas C5aR signals
are inhibitory. Overall, the net of C3aR and C5aR activation
promote C3aR-mediated proinflammatory effects, which
could reflect different pathways being used by the two
receptors and/or greater activation of C3aR, given relatively
more efficient alternative pathway cleavage of C3 than C5.
The mechanisms behind this, as well as the proinflammatory
signals delivered to inflammatory cells lacking both C3aR and
C5aR, which could occur through non-complement recep-
tors and/or G-protein-coupled receptor 77 (C5L2) for
C5a,47,48 remain to be established.
Taken together, we provide evidence that C3aR signal-
ing in cells outside the kidney is essential in comple-
ment activation-induced TI injury. Mechanisms of injury
include the recruitment of monocyte/macrophages and
T cells, leading to tubular cell injury, collagen I and III
deposition in the TI, and renal failure. Our results indicate
that blocking C3aR signaling may be a feasible treatment
in inflammatory TI injury associated with complement
activation.
MATERIALS AND METHODS
Mice
Crryþ / and C3þ / mice3,49 were kindly provided by Dr Hector
Molina (Washington University School of Medicine, St Louis, MO)
and were each crossed with WT C57BL/6 mice for at least 10
generations. C3þ / mice were intercrossed to generate C3/ mice,
which were crossed with Crryþ / mice to produce C3þ /Crryþ /
mice. These were then intercrossed to generate Crry/C3/
animals. Genotyping for Crry and C3 was performed using PCR-
based approaches3,49 on purified tail DNA (DNeasy Tissue kit,
Qiagen, Valencia, CA). C3aR/ and C5aR/ mice35,50 were
generated and kindly provided by Drs Craig Gerard and Allison
Humbles (Harvard Medical School, Boston, MA) and were each
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crossed with WT C57BL/6 mice for at least 10 generations. C3aRþ /
and C5aRþ / mice were each intercrossed to generate C3aR/ and
C5aR/ mice used in these studies. C3aR/ and C5aR/ mice
were also intercrossed to produce C3aRþ /C5aRþ / mice, which
were further intercrossed to generate C3aR/C5aR/ animals.
Genotyping for C3aR and C5aR was performed using PCR-based
approaches.35,50
Mouse experimental protocols
All experimental procedures performed here were approved by
the University of Chicago animal care and use committee. Mice
between 8 and 10 weeks old were used as kidney donors or
transplant recipients. Kidney donors were anesthetized and the
donor left kidney was removed with artery, vein, and ureter
attached, and preserved in cold saline on ice. The recipient was then
anesthetized and the left kidney was excised. Renal transplantation
was performed with end-to-side anastomoses of the donor renal
vein, artery, and ureter to the recipient inferior vena cava, aorta, and
bladder, respectively.51 Total cold ischemic time ranged between
45 and 60 min.
In the first sets of studies to assess renal function and renal
fibrosis of the transplanted kidneys, Crry/C3/ kidneys were
transplanted into C3aR/ (n¼ 5), C5aR/ (n¼ 6), C3aR/
C5aR/ (n¼ 6), or WT (n¼ 5) hosts. The left native kidney was
removed at the time of renal transplantation, whereas the remaining
right native kidney was removed 7 days post transplantation. Thus,
these mice relied solely on the transplanted kidney to provide renal
function.
In subsequent studies, kidneys from Crry/C3/ mice
were transplanted into C3aR/ (n¼ 8), C5aR/ (n¼ 7),
C3aR/C5aR/ (n¼ 6), or WT (n¼ 5) recipients. In these
experiments, one recipient kidney was left in place to provide renal
function. The transplanted kidneys were harvested at 7 days after
kidney transplantation. Blood urea nitrogen concentrations in all
animals at the time of killing were determined with a Beckman
Autoanalyzer (Beckman Coulter, Fullerton, CA).
Measurements from tissue
Sections (4 mm) of 4% paraformaldehyde-fixed paraffin-embedded
kidney tissue were stained with periodic acid-Schiff and examined
by a renal pathologist (MH) in a blinded manner. For each slide, the
severity of TI nephritis was graded from 0 to 4 in 0.5 increments as
previously described.52 Using this protocol, glomerular and vascular
compartments were also assessed carefully for pathological features.
For immunofluorescence microscopy, 4-mm cryostat sections
were fixed in ether–ethanol and stained with fluorescein isothiocya-
nate anti-mouse C3 (Cappel Pharmaceuticals, Aurora, OH). For
double immunofluorescence staining, ether–ethanol-fixed sections
were first incubated with rat anti-mouse CD11b (AbD Serotec,
Oxford, UK), followed by Alexa Fluor 488-conjugated anti-rat IgG
(Molecular Probes, Eugene, OR) and biotin-conjugated antibody to
human collagen I or III (reactive with mouse collagen I or III but
not other mouse collagens; SouthernBiotech, Birmingham, AL).
Specific collagen I or III staining was detected by Alexa Fluor 594-
conjugated Streptavidin (Molecular Probes). The staining intensities
of C3 and collagen I or III in the TI were semiquantitatively scored
from 0 to 3 by an observer blinded to the origin of the specimens as
previously described by others.53
For immunohistochemistry, zinc-fixed and paraffin-embedded
kidney sections were used. Endogenous peroxidases and biotin were
blocked with 0.3% H2O2 and Avidin/Biotin Blocking Kit (Vector
Laboratories, Burlingame, CA) followed by 10% normal mouse
serum. The slides were then incubated with rat anti-mouse 7/4
(AbD Serotec), anti-mouse B220 (BD Pharmingen, San Jose, CA),
anti-mouse Thy1.2 (BD Pharmingen), or anti-mouse F4/80
(AbD Serotec), followed by goat anti-rat IgG (BD Pharmingen)
and streptavidin-peroxidase (Sigma/Aldrich, St Louis, MO). Speci-
fically bound antibodies were detected using a 3,30-diaminobenzi-
dine (DAB)-based technique (ImmPACT DAB, Vector Laboratories)
with methyl-green counterstaining. To quantify positive cells for
each marker in the TI within renal cortices, at least twenty  200
fields of the cortical TI were examined by an observer masked to
origin of the slides.54
Given the large number of Thy1.2þ T cells, F4/80þ , and 7/4þ
cells present in the TI, double immunohistochemistry staining was
then performed to compare the distribution of different inflamma-
tory cell types. Slides were first stained with rat anti-mouse Thy1.2
or anti-mouse 7/4 mAbs as described above. The specific mAb
binding was detected by DAB development, which resulted in a
brown color. The peroxidases and biotin in the first staining were
blocked by 0.3% hydrogen peroxide and the Avidin/Biotin Blocking
Kit. Slides were then incubated with rat anti-mouse F4/80 or anti-
mouse B220 as described above. Specific signal was detected with the
VIP Substrate Kit (Vector), leading to a purple color, followed by
methyl-green counterstaining.
Flow cytometry
Renal-infiltrating cells were isolated as described previously.55 In
brief, mouse kidneys were minced and digested at 37 1C for 45 min
with gentle agitation with collagenase I (2 mg ml–1) and DNAse I
(100 mg ml–1) in Hank’s buffered salt solution/1% (vol/vol) bovine
serum albumin (all from Sigma/Aldrich). Erythrocytes were lysed
with NH4Cl and the cell suspension was passed through a 40mm cell
strainer (BD Biosciences, Franklin Lakes, NJ). Isolated cells (B106)
from each mouse were stained with APC-F4/80, PE-Gr1, Alexa
488-anti-CD11b (Mac-1) (each from AbD Serotec), and PE-Cy7-
anti-CD11c (HL3) (BD Pharmingen. Flow cytometry was performed
with a FACSCanto (BD Biosciences) and analyzed with FlowJo
software (Tree Star, Ashland, OR).
Statistical analyses
Numeric data from all experiments were first analyzed using the
‘graphical summary’ function in Minitab 15 (State College, PA) to
determine data normality (Anderson–Darling test) and 95% con-
fidence intervals for mean, median, and s.d. Parametric and
nonparametric data were then analyzed by one-way analysis of
variance and Kruskal–Wallis tests, respectively. When data sets were
significantly different by these measures, subsequent comparisons were
made by Tukey’s testing and sign CIs for parametric and nonpara-
metric data, respectively; appropriate corrections for multiple
comparisons were always incorporated in these analyses. In the
figures, values from individual mice from each group are presented,
whereas in Table 1, parametric data are presented as mean±s.e.m.,
and nonparametric data as median with the data range in parentheses.
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